Thyroid Cancer Clinical Trial
— TOETVAOfficial title:
Transoral Endoscopic Thyroidectomy by Vestibular Approach (TOETVA) Compared to Conventional Thyroidectomy by Cervical Approach: a Randomized Clinical Trial
NCT number | NCT05412680 |
Other study ID # | TOETVA |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | May 25, 2022 |
Est. completion date | December 31, 2024 |
Prospective study carried out with ICESP (instituto do Câncer do Estado de São Paulo) patients with thyroid disease with surgical indication
Status | Recruiting |
Enrollment | 60 |
Est. completion date | December 31, 2024 |
Est. primary completion date | December 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria: - history of hypertrophic scarring and/or motivation to avoid cervical scarring, - maximum diameter of the thyroid < 10 cm and of the dominant nodule < 6 cm, - estimated thyroid volume < 45 ml - benign lesion (multinodular goiter, cyst), - indeterminate nodule (Bethesda III or IV), - suspicious nodule for well-differentiated thyroid carcinoma (Bethesda V and VI) < 2 cm Exclusion Criteria: - history of previous surgery or irradiation in the head and neck region and superior mediastinum - evidence of clinical hyperthyroidism - preoperative recurrent nerve palsy - lymph node metastasis - extra-thyroid extension - plunging goiter - oral abscess |
Country | Name | City | State |
---|---|---|---|
Brazil | ICESP | São Paulo | SP |
Lead Sponsor | Collaborator |
---|---|
Fábio de Aquino Capelli |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | To compare TOETVA technique with conventional thyroidectomy in terms of operative time | Operative time will be measured by minutes | 1 year | |
Primary | To compare TOETVA technique with conventional thyroidectomy in terms of post operative surgical complications, such as laryngeal nerve dysfunction | This outcome will be accessed by performing laryngoscopy before and after the surgery | 1 year | |
Primary | To compare TOETVA technique with conventional thyroidectomy in terms of post operative surgical complications, such as hypoparathyroidism | This outcome will be accessed by accessing de blood calcium and parathormone levels after the surgery | 1 year | |
Primary | To compare TOETVA technique with conventional thyroidectomy in terms of post operative surgical complications, such as hematoma formation | This outcome will be accessed by qualitative analysis | 1 year | |
Primary | To compare TOETVA technique with conventional thyroidectomy in terms of post operative surgical complications, such as seroma formation | This outcome will be accessed by qualitative analysis | 1 year | |
Primary | To compare TOETVA technique with conventional thyroidectomy in terms of post operative surgical complications, such as skin injury | This outcome will be accessed by qualitative analysis | 1 year | |
Primary | To compare TOETVA technique with conventional thyroidectomy in terms of post operative pain | This outcome will be accessed by visual pain scale from grade 1 (better) to 10 (worse) | 1 year | |
Primary | To compare TOETVA technique with conventional thyroidectomy in terms of time of hospitalization | This outcome will be accessed by number of days spent in the hospital | 1 year | |
Secondary | Comparison on quality of life - questionnaire 1. | Quality of life evaluated by specific questionnaires, such as University of Washington version 4 - 0 (worse) 1200 (better) | 1 year | |
Secondary | Comparison on quality of life - questionnaire 2. | Quality of life evaluated by specific questionnaires, such as Dermatology life quality index - 0 (better) 30 (worse) | 1 year | |
Secondary | Comparison on quality of life - questionnaire 3. | Quality of life evaluated by specific questionnaires, such as Euroqol - 5D - 5 (better) 15 (worse) | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05774535 -
Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery
|
||
Withdrawn |
NCT04224792 -
Effects of Exercise Training on Fatigue in Thyroid Cancer Survivors
|
N/A | |
Completed |
NCT01728623 -
A Study of E7080 in Subjects With Advanced Thyroid Cancer
|
Phase 2 | |
Recruiting |
NCT03175224 -
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
|
Phase 2 | |
Completed |
NCT02911155 -
Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists
|
||
Recruiting |
NCT05025046 -
NGS-based Thyroscan Genomic Classifier in the Diagnosis of Thyroid Nodules
|
||
Not yet recruiting |
NCT03978351 -
The Role of Midkine in Diagnosis of Thyroid Cancer
|
||
Completed |
NCT02658513 -
Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer
|
||
Terminated |
NCT02628535 -
Safety Study of MGD009 in B7-H3-expressing Tumors
|
Phase 1 | |
Completed |
NCT02375451 -
Effect of Childhood Radioiodine Therapy on Salivary Function
|
N/A | |
Withdrawn |
NCT01994200 -
Developing and Implementing an Interdisciplinary Team-Based Care Approach (ITCA-ThyCa) for Thyroid Cancer Patients
|
Phase 1/Phase 2 | |
Terminated |
NCT01403324 -
Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer
|
N/A | |
Completed |
NCT00970359 -
Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244
|
N/A | |
Completed |
NCT00439478 -
Dental Safety Profile of High-Dose Radioiodine Therapy
|
Phase 4 | |
Completed |
NCT00223158 -
Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer
|
N/A | |
Active, not recruiting |
NCT04544111 -
PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer
|
Phase 2 | |
Completed |
NCT04876287 -
Salivary dysfuncTion After Radioiodine Treatment
|
||
Recruiting |
NCT06073223 -
Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer
|
N/A | |
Recruiting |
NCT06037174 -
Comparison of Quality of Life in Patients With Differentiated Thyroid Carcinoma Undergoing Different Surgery
|
||
Recruiting |
NCT04952493 -
Anlotinib or Penpulimab in Combination With RAI for DTC
|
Phase 2 |